Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

Ligand Pharmaceuticals Incorporated

LGND ✗ NOT COMPLIANTFree checks used up today ☆ Track — members
NASDAQ · Healthcare · Pharmaceuticals ·
USA Mid Cap Analyst: BUY
Last Close
$311.13
▲ +3.09%
Market Cap $6.20B · Vol 57.18K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
33.09
FWD: 27.48
Market Cap
$6.20B
Mid Cap
Div Yield
N/A
Dividend with no set frequency
EPS Growth
+13.87%
YoY
RSI (14)
59.49
Momentum
Beta
1.21
vs Market
52W High
$324.99
4.26% below
52W Low
$176.31
76.47% above
Volume
57.18K
Avg 79.28K
P/B
3.68
Price-to-book
ROE
17.87%
Return on equity
Free Float
97.68%
Public shares
Shariah Compliance8 STANDARDS
✗ Ligand Pharmaceuticals Incorporated (LGND) stock is currently not Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LGND pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
+1.42%
1M
+9.37%
3M
-1.62%
6M
+51.83%
YTD
+64.56%
1Y
+75.06%
3Y
+465.79%
5Y
+289.41%
Financials & Valuation
TTM · Annual
Total Revenue$215.02M
Net Income$124.45M
Revenue Growth (YoY)+33.73%
Gross Margin78.02%
Operating Margin-0.59%
Net Profit Margin57.88%
ROE17.87%
ROA · ROIC12.70% · 11.17%
P/E Ratio33.09
Forward P/E (FY1)27.48
PEG Ratio0.01
P/S17.85
P/B3.68
P/FCF78.45
EPS Growth+13.87%
Outstanding Shares19.94M
Technical Indicators
50-Day SMA$292.51
200-Day SMA$244.87
RSI (14)59.49
Beta1.21
52-Week High$324.99
52-Week Low$176.31
Volume Today57.18K
Avg Daily Volume (30D)79.28K
Relative Volume0.72x
Volatility (10D)31.66
Volatility (30D)27.84
Free Float97.68%
AAOIFI Certified Shariah Advisor and Auditor certificate